European Investment Bank lends Novozymes $122M for R&D

In Denmark, the European Investment Bank (EIB) has signed a $122 million loan with Novozymes. The financing will support the company’s R&D investment plans for the coming years, and will mainly benefit R&D activities for discovering and producing enzymes that can be used in both industrial and home activities, reducing the need for traditional chemical products.

The research, development and innovation activities supported under this financing will be carried out at Novozymes’ R&D facilities in Bagsværd and Lyngby in Denmark. Since 2004, the European Investment Bank has made available €740 million to support Novozymes’ research and development activities and the previous loan was signed in early 2019.